Federal award (DEFINITIVE CONTRACT, fiscal year 2021)
Recipient: PROTEIOS TECHNOLOGY, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-09-13 to 2022-06-12
Current total value of award: $400000
Description: EO14042-TOPIC 429 A NEW PARADIGM FOR AUTOLOGOUS AND ALLOGENEIC CELL THERAPY MANUFACTURING PERIOD OF PERFORMANCE SEPTEMBER 13, 2021-JUNE 12, 2022 FY21 PHASE I SBIR